General
Showing 1009–1024 of 1897 results
-
Article: O.1 ABVD (8 cycles) vs. BEACOPP (4 escalated cycles => 4 baseline) in stage III – IV low risk Hodgkin Lymphoma (IPS 0–2): final results of LYSA H34 trial
€2.42 Add to cart -
Article: O.1 Exome sequencing identifies mutation of the ribosome in T-ALL
€2.42 Add to cart -
Article: O.1 Infusion of mesenchymal stem cells (MSC) as treatment for steroid refractory acute graft-versus-host study (aGVHD): a multicenter prospective phase II study of the BHS
€2.42 Add to cart -
Article: O.1 Real World Population-Based Exploration of the Pathology Subtyping and Treatment-Modalities of Diffuse Large B-Cell Lymphoma in Belgium in Relation to Survival
€2.42 Add to cart -
Article: O.1 Results from the Belgian mantle cell lymphoma registry
€2.42 Add to cart -
Article: O.2 A single analysis for simultaneous measurement of all 4 DOACs
€2.42 Add to cart -
Article: O.2 Analysis of Phenotype and Outcome in Essential Thrombocythemia with CALR and JAK2 mutations
€2.42 Add to cart -
Article: O.2 AXL: A potential therapeutic target to eliminate cancer cells and improve chemotherapeutic responses in different hematological cancers
€2.42 Add to cart -
Article: O.2 Establishment of a murine graft-versus-myeloma model using allogeneic stem cell transplantation
€2.42 Add to cart -
Article: O.2 Nanobodies as new imaging tools in multiple myeloma: a study in the 5T2MM murine model
€2.42 Add to cart -
Article: O.2 RPL5 on 1p22.1 is recurrently deleted in multiple myeloma and its expression is linked to bortezomib response
€2.42 Add to cart -
Article: O.3 Comparison of 2 nonmyeloablative regimens for allogeneic HCT: a phase II randomized study from the HCT committee of the BHS
€2.42 Add to cart -
Article: O.3 Donor Characteristics As Pretransplant Predictive Factors of Long-Term Outcomes After Allogeneic Peripheral Blood (PB) Stem Cell Transplantation (SCT) From HLA-Matched Related and Unrelated Donors in Patients with Hematologic Malignancies
€2.42 Add to cart -
Article: O.3 IgHV Mutational Status Analysis By Next-Generation Deep Sequencing In Chronic Lymphocytic Leukemia Patients: Prognostic Significance Of Multiple Subclones And Implication For Disease Cell Origin
€2.42 Add to cart -
Article: O.3 Maternal Embryonic Leucine Zipper Kinase (MELK) Drives a High-Risk Gene Network and Represents an attractive Novel Drug Target in Multiple Myeloma and its associated Bone Disease
€2.42 Add to cart -
Article: O.3 Palliative cytoreduction with low dose intravenous melphalan in patients with acute myeloid leukemia refractory to prior treatment
€2.42 Add to cart
